Nuedexta in Agitated Dementia
The Carlat Psychiatry Report, Volume 18, Number 2, February 2020
https://www.thecarlatreport.com/newsletter-issue/tcprv18n2/
Issue Links: Learning Objectives | Editorial Information
Topics: Agitation | Dementia | Generics | Nuedexta | Pharmaceutical Industry | pseudobulbar affect
Nuedexta is indicated for pseudobulbar affect, but when the manufacturer attempted to expand its use into agitation in dementia they ran into some heavy legal penalties. Here we take a closer look at the published and unpublished trials to see what ─ if anything ─ is salvageable. We’ll also show you how to prescribe this high-cost drug as a generic equivalent.
You can't view details of this content, please login or buy subscription here